Benaroya Research Institute (BRI) has been invited by the new Allen Institute for Immunology to partner in its first phase of research, along with other leading research organizations, to understand the dynamic balancing act of the human immune system, how it distinguishes friend from foe and what goes wrong when we’re ill.
BRI’s role will be to provide new, detailed information about the normal, healthy immune system to serve as a foundation for existing and future disease research programs. To accomplish this, BRI will recruit healthy adults in specific age ranges, 25 to 35 years and 55 to 65 years, from the Seattle area.
The goal of the project is to shed light on the various factors — lifestyle, environmental exposures and vaccines — that can impact the immune system.
BRI joins research partners Fred Hutchinson Cancer Research Center, the University of California San Diego with the University of Colorado Anschutz Medical Campus and the University of Pennsylvania in this large-scale team science, multiyear project. Initially, the partnership will focus on three autoimmune disorders, rheumatoid arthritis, ulcerative colitis and Crohn’s disease; and two cancers, multiple myeloma and melanoma, in addition to the study of healthy immune systems.More Stories